We are live on ! Find out more
LLY icon

Eli Lilly

4,631 hedge funds and large institutions have $899B invested in Eli Lilly in 2026 Q3 according to their latest regulatory filings, with 212 funds opening new positions, 2,232 increasing their positions, 1,623 reducing their positions, and 145 closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more first-time investments, than exits

New positions opened: 212 | Existing positions closed: 145

38% more repeat investments, than reductions

Existing positions increased: 2,232 | Existing positions reduced: 1,623

1% less funds holding

Funds holding: 4,673 → 4,631 (-42)

5% less call options, than puts

Call options by funds: $17B | Put options by funds: $18B

1.6% less ownership

Funds ownership: 84.13% → 82.53% (-1.6%)

6% less funds holding in top 10

Funds holding in top 10: 478 → 448 (-30)

27% less capital inflows, than outflows

Capital inflows: $27.8B | Capital outflows: $38.2B

Holders
4,631
Holders Change
-42
Holders Change %
-0.9%
% of All Funds
56.29%
Holding in Top 10
448
Holding in Top 10 Change
-30
Holding in Top 10 Change %
-6.28%
% of All Funds
5.45%
New
212
Increased
2,232
Reduced
1,623
Closed
145
Calls
$17​B
Puts
$18​B
Net Calls
-⁠$939​M
Net Calls Change
-⁠$5.5​B

LLY Hedge Fund Activity: Q3 2026 in Review

4,631 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q3 2026, worth a combined $899B — down 5.2% from $949B a quarter earlier.

Buyers outnumbered sellers: 212 funds opened new LLY positions and 145 closed out — a net gain of 67 holders — while 2,232 added to existing stakes and 1,623 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $1.77B. The largest seller was Royal Bank of Canada, cutting an estimated $5.4B.

  • 4,631 institutional investors held Eli Lilly (LLY) as of Q3 2026, down from 4,673 in Q2 2026.
  • Funds reported $899B of Eli Lilly stock for Q3 2026, down 5.2% quarter-over-quarter.
  • 212 funds opened new Eli Lilly positions in Q3 2026 and 145 closed out, a net change of +67 holders.
  • The largest Eli Lilly buyer in Q3 2026 was Fidelity Investments, an estimated $1.77B added.
  • The largest Eli Lilly seller in Q3 2026 was Royal Bank of Canada, an estimated $5.4B sold.

Based on aggregated 13F filings for Q3 2026.